"Source Name" "Characteristics[organism]" "Term Source REF" "Term Accession Number" "Characteristics[sex]" "Term Source REF" "Term Accession Number" "Characteristics[patient number]" "Term Source REF" "Term Accession Number" "Characteristics[AJCC Stage]" "Term Source REF" "Term Accession Number" "Characteristics[Pathological T]" "Term Source REF" "Term Accession Number" "Characteristics[Pathological N]" "Term Source REF" "Term Accession Number" "Characteristics[Pathological M]" "Term Source REF" "Term Accession Number" "Characteristics[Tumor Grade]" "Term Source REF" "Term Accession Number" "Comment[description]" "Factor Value[tumor site]" "Term Source REF" "Term Accession Number" "Factor Value[tumor type]" "Term Source REF" "Term Accession Number" "Characteristics[tumor tissue type]" "Term Source REF" "Term Accession Number" "Factor Value[NSAID treatment]" "Term Source REF" "Term Accession Number" "Factor Value[NSAID dosage]" "Unit" "Term Source REF" "Term Accession Number" "Protocol REF" "Sample Name" "GSM283127" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4858" "" "" "IV" "" "" "3" "" "" "1" "" "" "1" "" "" "moderate" "" "" "Celecoxib_#4858: 4858. Gender: Male; AJCC Stage: IV; Pathological T: 3; Pathological N: 1; Pathological M: 1; Grade: moderate; Tumor Site: Sigmoid; Drug Treatment: YES" "colon sigmoideum" "BTO" "BTO:0000645" "sigmoid colon cancer" "DOID" "DOID:12192" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283127 sample" "GSM283128" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4860" "" "" "III" "" "" "3" "" "" "1" "" "" "0" "" "" "poor" "" "" "No_drug_#4860: 4860. Gender: Female; AJCC Stage: III; Pathological T: 3; Pathological N: 1; Pathological M: 0; Grade: poor; Tumor Site: Cecum; Drug Treatment: NO" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283128 sample" "GSM283129" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4867" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "moderate" "" "" "Celecoxib_#4867: 4867. Gender: Male; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Cecum; Drug Treatment: YES" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283129 sample" "GSM283130" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4868" "" "" "III" "" "" "3" "" "" "1" "" "" "0" "" "" "moderate" "" "" "No_drug_#4868: 4868. Gender: Male; AJCC Stage: III; Pathological T: 3; Pathological N: 1; Pathological M: 0; Grade: moderate; Tumor Site: Rectosigmoid; Drug Treatment: NO" "Rectosigmoid Colon" "NCIt" "C103438" "rectosigmoid cancer" "DOID" "DOID:2781" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283130 sample" "GSM283131" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4870" "" "" "II" "" "" "4" "" "" "0" "" "" "0" "" "" "poor" "" "" "No_drug_#4870: 4870. Gender: Male; AJCC Stage: II; Pathological T: 4; Pathological N: 0; Pathological M: 0; Grade: poor; Tumor Site: Hepatic Flexure; Drug Treatment: NO" "Hepatic Flexure" "NCIt" "C12266" "hepatic flexure cancer" "DOID" "DOID:260" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283131 sample" "GSM283132" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4871" "" "" "I" "" "" "2" "" "" "0" "" "" "0" "" "" "well" "" "" "Celecoxib_#4871: 4871. Gender: Female; AJCC Stage: I; Pathological T: 2; Pathological N: 0; Pathological M: 0; Grade: well; Tumor Site: Sigmoid; Drug Treatment: YES" "colon sigmoideum" "BTO" "BTO:0000645" "sigmoid colon cancer" "DOID" "DOID:12192" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283132 sample" "GSM283133" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4872" "" "" "I" "" "" "2" "" "" "0" "" "" "0" "" "" "moderate" "" "" "No_drug_#4872: 4872. Gender: Female; AJCC Stage: I; Pathological T: 2; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Cecum; Drug Treatment: NO" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283133 sample" "GSM283134" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4873" "" "" "III" "" "" "3" "" "" "1" "" "" "0" "" "" "moderate" "" "" "Celecoxib_#4873: 4873. Gender: Female; AJCC Stage: III; Pathological T: 3; Pathological N: 1; Pathological M: 0; Grade: moderate; Tumor Site: Ascending; Drug Treatment: YES" "ascending colon" "BTO" "0000270" "ascending colon cancer" "DOID" "DOID:218" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283134 sample" "GSM283135" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4874" "" "" "IV" "" "" "3" "" "" "0" "" "" "1" "" "" "well" "" "" "Celecoxib_#4874: 4874. Gender: Female; AJCC Stage: IV; Pathological T: 3; Pathological N: 0; Pathological M: 1; Grade: well; Tumor Site: Hepatic Flexure; Drug Treatment: YES" "Hepatic Flexure" "NCIt" "C12266" "hepatic flexure cancer" "DOID" "DOID:260" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283135 sample" "GSM283136" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4875" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "moderate to poor" "" "" "Celecoxib_#4875: 4875. Gender: Male; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: moderate to poor; Tumor Site: Descending; Drug Treatment: YES" "descending colon" "BTO" "0000641" "descending colon cancer" "DOID" "DOID:12190" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283136 sample" "GSM283137" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4876" "" "" "I" "" "" "2" "" "" "0" "" "" "0" "" "" "moderate" "" "" "No_drug_#4876: 4876. Gender: Male; AJCC Stage: I; Pathological T: 2; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Cecum; Drug Treatment: NO" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283137 sample" "GSM283138" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4877" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "poor" "" "" "Celecoxib_#4877: 4877. Gender: Male; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: poor; Tumor Site: Cecum; Drug Treatment: YES" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283138 sample" "GSM283139" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4879" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "well" "" "" "No_drug_#4879: 4879. Gender: Female; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: well; Tumor Site: Ascending; Drug Treatment: NO" "ascending colon" "BTO" "0000270" "ascending colon cancer" "DOID" "DOID:218" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283139 sample" "GSM283140" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4881" "" "" "IV" "" "" "3" "" "" "2" "" "" "1" "" "" "moderate" "" "" "No_drug_#4881: 4881. Gender: Female; AJCC Stage: IV; Pathological T: 3; Pathological N: 2; Pathological M: 1; Grade: moderate; Tumor Site: Sigmoid; Drug Treatment: NO" "colon sigmoideum" "BTO" "BTO:0000645" "sigmoid colon cancer" "DOID" "DOID:12192" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283140 sample" "GSM283141" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4882" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "moderate" "" "" "No_drug_#4882: 4882. Gender: Female; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Sigmoid; Drug Treatment: NO" "colon sigmoideum" "BTO" "BTO:0000645" "sigmoid colon cancer" "DOID" "DOID:12192" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283141 sample" "GSM283142" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4859" "" "" "I" "" "" "1" "" "" "0" "" "" "0" "" "" "moderate" "" "" "Celecoxib_#4859: 4859. Gender: Female; AJCC Stage: I; Pathological T: 1; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Ascending; Drug Treatment: YES" "ascending colon" "BTO" "0000270" "ascending colon cancer" "DOID" "DOID:218" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283142 sample" "GSM283143" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4865" "" "" "IV" "" "" "4" "" "" "1" "" "" "1" "" "" "moderate" "" "" "No_drug_#4865: 4865. Gender: Male; AJCC Stage: IV; Pathological T: 4; Pathological N: 1; Pathological M: 1; Grade: moderate; Tumor Site: Ascending; Drug Treatment: NO" "ascending colon" "BTO" "0000270" "ascending colon cancer" "DOID" "DOID:218" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283143 sample" "GSM283144" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4863" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "moderate" "" "" "No_drug_#4863: 4863. Gender: Female; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Sigmoid; Drug Treatment: NO" "colon sigmoideum" "BTO" "BTO:0000645" "sigmoid colon cancer" "DOID" "DOID:12192" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283144 sample" "GSM283145" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4861" "" "" "III" "" "" "3" "" "" "1" "" "" "0" "" "" "moderate" "" "" "Celecoxib_#4861: 4861. Gender: Male; AJCC Stage: III; Pathological T: 3; Pathological N: 1; Pathological M: 0; Grade: moderate; Tumor Site: Cecum; Drug Treatment: YES" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283145 sample" "GSM283146" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4862" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "moderate" "" "" "No_drug_#4862: 4862. Gender: Female; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Rectosigmoid; Drug Treatment: NO" "Rectosigmoid Colon" "NCIt" "C103438" "rectosigmoid cancer" "DOID" "DOID:2781" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283146 sample" "GSM283147" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4880" "" "" "IV" "" "" "4" "" "" "0" "" "" "1" "" "" "moderate" "" "" "Celecoxib_#4880: 4880. Gender: Female; AJCC Stage: IV; Pathological T: 4; Pathological N: 0; Pathological M: 1; Grade: moderate; Tumor Site: Sigmoid; Drug Treatment: YES" "colon sigmoideum" "BTO" "BTO:0000645" "sigmoid colon cancer" "DOID" "DOID:12192" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283147 sample" "GSM283148" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "male" "EFO" "EFO_0000685" "4866" "" "" "IV" "" "" "3" "" "" "1" "" "" "1" "" "" "moderate" "" "" "Celecoxib_#4866: 4866. Gender: Male; AJCC Stage: IV; Pathological T: 3; Pathological N: 1; Pathological M: 1; Grade: moderate; Tumor Site: Ascending; Drug Treatment: YES" "ascending colon" "BTO" "0000270" "ascending colon cancer" "DOID" "DOID:218" "adenocarcinoma" "DOID" "DOID:299" "celecoxib" "CHEBI" "CHEBI:41423" "400" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283148 sample" "GSM283149" "Homo sapiens" "NCBITaxon" "obo:NCBITaxon_9606" "female" "EFO" "EFO_0002506" "4864" "" "" "II" "" "" "3" "" "" "0" "" "" "0" "" "" "moderate" "" "" "No_drug_#4864: 4864. Gender: Female; AJCC Stage: II; Pathological T: 3; Pathological N: 0; Pathological M: 0; Grade: moderate; Tumor Site: Cecum; Drug Treatment: NO" "cecum" "BTO" "BTO:0000166" "cecum cancer" "DOID" "DOID:1521" "adenocarcinoma" "DOID" "DOID:299" "control condition" "XCO" "XCO:0000099" "0" "mg BID x 7d pre-resection" "" "" "P-G11237-1" "GSM283149 sample"